AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from our boron chemistry platform. We have a pipeline of boron-based compounds in development for Chagas disease, NTM, and melioidosis,...
Read More